de Royce & Associates Healthcare Services Group HCSG Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 55 M | Comprar |
2,239,224
+95,987
| +4% | +USD 2.03 M | 0.44% | 41 |
|
|
2026
Q1 | USD 39.8 M | Vender |
2,143,237
-149,658
| -7% | -USD 2.95 M | 0.39% | 58 |
|
|
2025
Q4 | USD 43.8 M | Vender |
2,292,895
-572,102
| -20% | -USD 10.3 M | 0.44% | 43 |
|
|
2025
Q3 | USD 48.2 M | Vender |
2,864,997
-170,127
| -6% | -USD 2.53 M | 0.48% | 34 |
|
|
2025
Q2 | USD 45.6 M | Vender |
3,035,124
-1,648,914
| -35% | -USD 21.9 M | 0.47% | 41 |
|
|
2025
Q1 | USD 47.2 M | Comprar |
4,684,038
+15,439
| +0.3% | +USD 169 k | 0.51% | 33 |
|
|
2024
Q4 | USD 54.2 M | Comprar |
4,668,599
+219,103
| +5% | +USD 2.5 M | 0.5% | 39 |
|
|
2024
Q3 | USD 49.7 M | Comprar |
4,449,496
+290,621
| +7% | +USD 3.19 M | 0.45% | 46 |
|
|
2024
Q2 | USD 44 M | Comprar |
4,158,875
+2,541
| +0.1% | +USD 28.2 k | 0.41% | 52 |
|
|
2024
Q1 | USD 51.9 M | Comprar |
4,156,334
+242,127
| +6% | +USD 2.68 M | 0.46% | 43 |
|
|
2023
Q4 | USD 40.6 M | Comprar |
3,914,207
+534,791
| +16% | +USD 5.34 M | 0.37% | 63 |
|
|
2023
Q3 | USD 35.2 M | Comprar |
3,379,416
+1,081,641
| +47% | +USD 13.5 M | 0.36% | 63 |
|
|
2023
Q2 | USD 34.3 M | Comprar |
2,297,775
+467,368
| +26% | +USD 6.77 M | 0.33% | 66 |
|
|
2023
Q1 | USD 25.4 M | Comprar |
1,830,407
+440,606
| +32% | +USD 5.8 M | 0.25% | 99 |
|
|
2022
Q4 | USD 16.7 M | Vender |
1,389,801
-246,428
| -15% | -USD 3.25 M | 0.18% | 156 |
|
|
2022
Q3 | USD 19.8 M | Vender |
1,636,229
-445,865
| -21% | -USD 6.57 M | 0.22% | 113 |
|
|
2022
Q2 | USD 36.2 M | Comprar |
2,082,094
+487,843
| +31% | +USD 8.41 M | 0.37% | 55 |
|
|
2022
Q1 | USD 29.6 M | Comprar |
1,594,251
+899,037
| +129% | +USD 15.5 M | 0.25% | 92 |
|
|
2021
Q4 | USD 12.4 M | Vender |
695,214
-440,103
| -39% | -USD 8.56 M | 0.09% | 350 |
|
|
2021
Q3 | USD 28.4 M | Comprar |
1,135,317
+9,418
| +0.8% | +USD 255 k | 0.21% | 127 |
|
|
2021
Q2 | USD 35.5 M | Comprar |
1,125,899
+4,405
| +0.4% | +USD 134 k | 0.24% | 100 |
|
|
2021
Q1 | USD 31.4 M | Comprar |
1,121,494
+24,168
| +2% | +USD 730 k | 0.21% | 134 |
|
|
2020
Q4 | USD 30.8 M | Comprar |
1,097,326
+493,925
| +82% | +USD 11.9 M | 0.25% | 96 |
|
|
2020
Q3 | USD 13 M | Comprar |
603,401
+184,126
| +44% | +USD 4.3 M | 0.14% | 208 |
|
|
2020
Q2 | USD 10.3 M | Comprar |
419,275
+253,291
| +153% | +USD 6 M | 0.11% | 261 |
|
|
2020
Q1 | USD 3.97 M | Vender |
165,984
-237
| -0.1% | -USD 6.09 k | 0.05% | 441 |
|
|
2019
Q4 | USD 4.04 M | Comprar |
166,221
+1,565
| +1% | +USD 38.8 k | 0.04% | 542 |
|
|
2019
Q3 | USD 4 M | Mantener |
164,656
| – | – | 0.04% | 533 |
|
|
2019
Q2 | USD 4.99 M | Mantener |
164,656
| – | – | 0.05% | 490 |
|
|
2019
Q1 | USD 5.43 M | Mantener |
164,656
| – | – | 0.05% | 492 |
|
|
2018
Q4 | USD 6.62 M | Vender |
164,656
-4,076
| -2% | -USD 172 k | 0.06% | 438 |
|
|
2018
Q3 | USD 6.85 M | Mantener |
168,732
| – | – | 0.05% | 499 |
|
|
2018
Q2 | USD 7.29 M | Mantener |
168,732
| – | – | 0.05% | 482 |
|
|
2018
Q1 | USD 7.34 M | Vender |
168,732
-21,400
| -11% | -USD 1.05 M | 0.05% | 467 |
|
|
2017
Q4 | USD 10 M | Vender |
190,132
-29,568
| -13% | -USD 1.55 M | 0.07% | 396 |
|
|
2017
Q3 | USD 11.9 M | Vender |
219,700
-16,200
| -7% | -USD 833 k | 0.08% | 339 |
|
|
2017
Q2 | USD 11 M | Vender |
235,900
-9,800
| -4% | -USD 453 k | 0.07% | 367 |
|
|
2017
Q1 | USD 10.6 M | Mantener |
245,700
| – | – | 0.07% | 371 |
|
|
2016
Q4 | USD 9.6 M | Vender |
245,700
-79,764
| -25% | -USD 3.05 M | 0.06% | 394 |
|
|
2016
Q3 | USD 12.9 M | Mantener |
325,464
| – | – | 0.08% | 313 |
|
|
2016
Q2 | USD 13.5 M | Mantener |
325,464
| – | – | 0.09% | 299 |
|
|
2016
Q1 | USD 12 M | Vender |
325,464
-104,300
| -24% | -USD 3.62 M | 0.08% | 346 |
|
|
2015
Q4 | USD 15 M | Vender |
429,764
-87,500
| -17% | -USD 3.18 M | 0.09% | 303 |
|
|
2015
Q3 | USD 17.4 M | Vender |
517,264
-144,475
| -22% | -USD 4.88 M | 0.09% | 268 |
|
|
2015
Q2 | USD 21.9 M | Vender |
661,739
-116,900
| -15% | -USD 3.68 M | 0.09% | 277 |
|
|
2015
Q1 | USD 25 M | Vender |
778,639
-114,500
| -13% | -USD 3.7 M | 0.09% | 274 |
|
|
2014
Q4 | USD 27.6 M | Vender |
893,139
-3,900
| -0.4% | -USD 116 k | 0.1% | 269 |
|
|
2014
Q3 | USD 25.7 M | Vender |
897,039
-21,100
| -2% | -USD 587 k | 0.09% | 282 |
|
|
2014
Q2 | USD 27 M | Vender |
918,139
-7,700
| -0.8% | -USD 227 k | 0.08% | 303 |
|
|
2014
Q1 | USD 26.9 M | Comprar |
925,839
+107,200
| +13% | +USD 2.94 M | 0.08% | 301 |
|
|
2013
Q4 | USD 23.2 M | Comprar |
818,639
+17,100
| +2% | +USD 468 k | 0.07% | 349 |
|
|
2013
Q3 | USD 20.6 M | Comprar |
801,539
+15,500
| +2% | +USD 388 k | 0.06% | 367 |
|
|
2013
Q2 | USD 19.3 M | Comprar |
+786,039
| Nuevas | +USD 18.1 M | 0.06% | 366 |
|
Otros fondos que tienen HCSG en su cartera
Posición de Royce & Associates en HCSG: resumen de T2 2026
Royce & Associates aumentó su participación en Healthcare Services Group (HCSG) en 4.5% durante T2 2026, al comprar aproximadamente USD 2.03 M y elevar la posición a 2,239,224 acciones con un valor de USD 55 M. La posición representa 0.44% de la cartera y ocupa el puesto #41.
Royce & Associates reportó por primera vez una posición en HCSG en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 275 fondos que sigue Wall St. Rank mantienen una posición en HCSG.
- Al cierre de T2 2026, Royce & Associates tenía 2,239,224 acciones de Healthcare Services Group con un valor de USD 55 M.
- Royce & Associates compró 95,987 acciones de Healthcare Services Group en T2 2026, por un monto estimado de USD 2.03 M.
- Healthcare Services Group representó 0.44% de la cartera de Royce & Associates en T2 2026 y fue su posición número 41.
- Royce & Associates reportó por primera vez una posición en Healthcare Services Group en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 275 fondos que sigue Wall St. Rank tenían Healthcare Services Group en cartera.
Según el Informe 13F de Royce & Associates correspondiente a T2 2026, presentado el 14 ago 2026.